Heyu Chen

Heyu Chen is an Associate Director at AstraZeneca, where they focus on analytical development for Cell and Gene therapy products. They completed a Ph.D. in Biology from Shanghai Jiao Tong University, where they investigated mechanisms and therapeutic strategies for brain diseases. Prior to their current role, Heyu was a Postdoctoral Researcher at UT Southwestern Medical Center, where they developed novel CAR T therapies and antibodies for hematological malignancies and solid tumors.